Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 844 results for "gsk"

Glaxo fined $54.4 million in UK probe of pay-for-delay deals

GSK gets massive £37.6m fine for 'market abuse' in delaying g...

Britain's competition watchdog has fined pharmaceutical giant GlaxoSmithKline (GSK) £37.6m (€48.4m) for market abuse in striking deals to delay the launch of cheap generic copies of its former blockbuster antidepressant Seroxat. Britain's ... Irish Independent, 7 hours ago

210 images for gsk

Opposing Views, 1 day ago
Octafinance, 1 day ago
Reuters UK, 1 day ago
Yahoo! News Australia, 2 days ago
Octafinance, 2 days ago
Octafinance, 1 day ago, 3 days ago
MSN News US, 2 days ago
NDTV, 5 days ago
Business Standard, 4 days ago

CMA Fines GlaxoSmithKline and Several Generic Companies £45 million for Delaying Market Entry of Generic Paroxetine in the UK

The CMA issued an infringement decision today fining GlaxoSmithKline (GSK) and two other pharmaceutical companies a total of £45 million for delaying market entry of generic versions of GSK's blockbuster anti-depressant Seroxat (paroxetine) in the ...
 National Law Review21 hours ago British government fines GSK $54M for delaying generic drugs  Local Tech Wire1 day ago GSK fined millions over deals to delay generic competition  Pharmafile2 days ago GLAXOSMITHKLINE : UK Regulator Fines GSK Over Generic Drug Delay - Update  4 Traders2 days ago

GSK is fined £38m for delaying generic paroxetine

Clare Dyer The BMJ GlaxoSmithKline, the United Kingdom's biggest drug maker, has been fined more than £37.6m (€48m; $55m) for striking deals between 2001 and 2004 to stifle competition from generic drug manufacturers with its blockbuster ...
 British Medical Journal1 day ago GSK fined £37.6m over deals to stifle drug competition  ITV.com2 days ago
MedCity News

UK authorities fine GSK $A76.7m

BRITAIN'S competition authority has fined drugmaker GlaxoSmithKline STG37.6 million ($A76.7 million) for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace. THE fine levelled on Friday is the ... day ago BRIEF: British regulators fine GSK $54.5M [The Philadelphia Inquirer]  Pharmacy Choice1 day ago GSK fined $54.5 mn for stifling launch of rival generic drug  The Freepress Journal1 day ago Morning Read: GSK slapped with $54.68M fine over deals to avoid competition with generics  MedCity News1 day ago

GSK fined after anti-depressant sales probe in Britain

3 Min ago 0 0 London: One of the world's biggest pharmaceutical giants, GlaxoSmithKline (GSK), has been fined more than 37.1 pound sterling or $54 million, Britain's Competition and Markets Authority announced on Friday. GSK and other ...
 India Online.in1 day ago GSK fined 54 mln USD after probe into anti-depressant sales in Britain day ago XINHUA - GSK fined 54 mln USD after probe into anti-depressant sales in Britain  Namibia Press Agency1 day ago

Glaxo slapped with ₤37.6M fine for years-old pay-for-delay deal

In its first pay-for-delay decision, the U.K.'s Competition and Markets Authority (CMA) dings GlaxoSmithKline ( GSK +0.7%) for ₤37.6M ($54.4M) for its activities to delay generic competition to its antidepressant Seroxat (paroxetine) during the ...
 Seeking Alpha1 day ago U.K. slaps GSK with $54.4M fine for decade-old pay-for-delay deal  FiercePharma1 day ago

AFP - Britain-pharmaceutical-fine-GlaxoSmithKline

Britain-pharmaceutical-fine-GlaxoSmithKline Contributed by NAMPA / AFP. Drugs giant GSK fined £37m over 'pay-for-delay' deals London, Feb 12, 2016 (AFP) - Britain's competition watchdog on Friday fined drugmaker GlaxoSmithKline £37.6 million ...
 Namibia Press Agency1 day ago Drugs giant GSK fined £37m over 'pay-for-delay' deals  Yahoo! News1 day ago

Watchdog fines GSK £37m for paying to keep generic drugs out of UK market

The pharmaceuticals giant says it is appealing the decision GlaxoSmithKline (Other OTC: GLAXF - news ) is considering an appeal after the UK's competition watchdog fined the company more than £37m for allegedly paying drugs manufacturers ...
 Yahoo! Finance UK and Ireland1 day ago CMA fines GlaxoSmithKline £38m for generics delay scam  BullBearings2 days ago
Business Standard India

GSK Consumer Healthcare to focus on driving consumption

Plans innovation in offerings to expand consumer base
 Business Line4 days ago No cheer on demand front for GSK Consumer  Business Standard4 days ago GSK Consumer: No cheer on demand front  Smart Investor4 days ago
Contract Pharma

VBI Vaccines and GSK to evaluate LPV Platform for new vaccines with improved stability

US-based biopharmaceutical firm VBI Vaccines (VBI) and GlaxoSmithKline Biologicals (GSK) have entered into a research collaboration to evaluate VBI's LPV Platform, which helps in the development of vaccines and biologics with improved stability and ...
 Pharmaceutical Technology3 days ago VBI enters research collaboration with GSK to enhance vaccine stability  Pharma Business International3 days ago VBI inks vaccine development deal with Glaxo; shares up 13% premarket  Seeking Alpha4 days ago VBI and GSK in Research Collaboration  Contract Pharma4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - gsk
Get updated on latest news & your favorite topics right in your inbox!
More     Less